$24.94
0.64% yesterday
NYSE, Nov 20, 10:13 pm CET
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Pfizer Stock price

$24.94
-3.99 13.79% 1M
-3.59 12.58% 6M
-3.85 13.37% YTD
-5.04 16.81% 1Y
-26.26 51.29% 3Y
-10.16 28.94% 5Y
-3.90 13.51% 10Y
NYSE, Closing price Wed, Nov 20 2024
-0.16 0.64%
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Key metrics

Market capitalization $141.33b
Enterprise Value $199.36b
P/E (TTM) P/E ratio 33.53
EV/FCF (TTM) EV/FCF 24.23
EV/Sales (TTM) EV/Sales 3.32
P/S ratio (TTM) P/S ratio 2.35
P/B ratio (TTM) P/B ratio 1.53
Dividend yield 6.62%
Last dividend (FY23) $1.65
Revenue growth (TTM) Revenue growth -12.29%
Revenue (TTM) Revenue $60.11b
EBIT (operating result TTM) EBIT $9.81b
Free Cash Flow (TTM) Free Cash Flow $8.23b
Cash position $9.95b
EPS (TTM) EPS $0.74
P/E forward 15.80
P/S forward 2.25
EV/Sales forward 3.18
Short interest 1.09%
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Pfizer forecast:

12x Buy
44%
14x Hold
52%
1x Sell
4%

Analyst Opinions

27 Analysts have issued a Pfizer forecast:

Buy
44%
Hold
52%
Sell
4%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
60,113 60,113
12% 12%
100%
- Direct Costs 24,944 24,944
22% 22%
41%
35,169 35,169
3% 3%
59%
- Selling and Administrative Expenses 7,970 7,970
4% 4%
13%
- Research and Development Expense 10,494 10,494
8% 8%
17%
16,705 16,705
0% 0%
28%
- Depreciation and Amortization 6,892 6,892
12% 12%
11%
EBIT (Operating Income) EBIT 9,813 9,813
7% 7%
16%
Net Profit 4,273 4,273
59% 59%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Positive
The Motley Fool
about one hour ago
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
Positive
The Motley Fool
about 5 hours ago
2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
Neutral
Business Wire
about 5 hours ago
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for the novel antibacterial drug XACDURO® (sulbactam-durlobactam) in mainland China. Pfizer's affiliated companies will be exclusively authorized to undertake and perform certain commercialization activities for XACDURO® in mainla...
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 88,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today